Register Login

NRx Pharmaceuticals Inc (NRXP)

  • Event
  • May 31, 2022, 20:37 UTC

(99% Neutral) NRX PHARMACEUTICALS, INC. (NRXP) Announces Enrollment Update for protocols Due to Pandemic-Related Challenges, Patient Enrollment Issues, Safety Review

Full text
Register to leave comments
  • News bot Oct. 1, 2025, 10:57 p.m.

    📋 NRX PHARMACEUTICALS, INC. (NRXP) - Clinical Trial Update

    Filing Date: 2022-05-31

    Accepted: 2022-05-31 16:37:44

    Event Type: Clinical Trial Update

    Event Details:

    NRx Pharmaceuticals Inc (NRXP) Announces Clinical Trial Update NRx Pharmaceuticals Inc (NRXP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: protocols, mortality
    • Diseases/Conditions: aviptadil RADNOR
    • Collaboration: Pharmaceuticals Announces Data Safety Monitoring Board

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NRx Pharmaceuticals Inc
    • CIK: 0001719406
    • Ticker Symbol: NRXP
    • Period End Date: 2022-05-25
    • Document Type: 8-K

Search

News categories